NLRP4 negatively regulates type I interferon signaling by targeting the kinase TBK1 for degradation via the ubiquitin ligase DTX4
暂无分享,去创建一个
Yinyin Li | J. Cui | Liang Zhu | Dan Liu | Z. Songyang | Helen Y Wang | Rong-Fu Wang | Songyang Zhou
[1] Yong‐jun Liu,et al. The helicase DDX41 senses intracellular DNA mediated by the adaptor STING in dendritic cells , 2011, Nature Immunology.
[2] Y. Kong,et al. Mapping a dynamic innate immunity protein interaction network regulating type I interferon production. , 2011, Immunity.
[3] Z. Elazar,et al. TBK1 Mediates Crosstalk Between the Innate Immune Response and Autophagy , 2011, Science Signaling.
[4] Zhijian J. Chen,et al. NLRX1 negatively regulates TLR-induced NF-κB signaling by targeting TRAF6 and IKK. , 2011, Immunity.
[5] M. White,et al. TBK1 directly engages Akt/PKB survival signaling to support oncogenic transformation. , 2011, Molecular cell.
[6] K. Ishii,et al. NLRP4 Negatively Regulates Autophagic Processes through an Association with Beclin1 , 2011, The Journal of Immunology.
[7] H. Shu,et al. Glycogen synthase kinase 3β regulates IRF3 transcription factor-mediated antiviral response via activation of the kinase TBK1. , 2010, Immunity.
[8] A. Bowie,et al. IFI16 is an innate immune sensor for intracellular DNA , 2010, Nature Immunology.
[9] D. Philpott,et al. NLRC5 Limits the Activation of Inflammatory Pathways , 2010, The Journal of Immunology.
[10] Zhijian J. Chen,et al. NLRC5 Negatively Regulates the NF-κB and Type I Interferon Signaling Pathways , 2010, Cell.
[11] S. Akira,et al. Pattern Recognition Receptors and Inflammation , 2010, Cell.
[12] V. Vacic,et al. Identification, analysis, and prediction of protein ubiquitination sites , 2010, Proteins.
[13] F. You,et al. PCBP2 mediates degradation of the adaptor MAVS via the HECT ubiquitin ligase AIP4 , 2009, Nature Immunology.
[14] S. Bloor,et al. The TBK1 adaptor and autophagy receptor NDP52 restricts the proliferation of ubiquitin-coated bacteria , 2009, Nature Immunology.
[15] D. Feldser,et al. Requirement for NF-κB signalling in a mouse model of lung adenocarcinoma , 2009, Nature.
[16] Ben S. Wittner,et al. Systematic RNA interference reveals that oncogenic KRAS-driven cancers require TBK1 , 2009, Nature.
[17] Zhijian J. Chen,et al. RNA Polymerase III Detects Cytosolic DNA and Induces Type I Interferons through the RIG-I Pathway , 2009, Cell.
[18] V. Hornung,et al. RIG-I-dependent sensing of poly(dA:dT) through the induction of an RNA polymerase III–transcribed RNA intermediate , 2009, Nature Immunology.
[19] Nan Li,et al. The E3 ubiquitin ligase Nrdp1 'preferentially' promotes TLR-mediated production of type I interferon , 2009, Nature Immunology.
[20] L. O’Neill. When signaling pathways collide: positive and negative regulation of toll-like receptor signal transduction. , 2008, Immunity.
[21] J. Gatot,et al. Are the IKKs and IKK-related kinases TBK1 and IKK-epsilon similarly activated? , 2008, Trends in biochemical sciences.
[22] D. Philpott,et al. NLRX1 is a mitochondrial NOD‐like receptor that amplifies NF‐κB and JNK pathways by inducing reactive oxygen species production , 2008, EMBO reports.
[23] M. Heise,et al. NLRX1 is a regulator of mitochondrial antiviral immunity , 2008, Nature.
[24] F. Randow,et al. SINTBAD, a novel component of innate antiviral immunity, shares a TBK1‐binding domain with NAP1 and TANK , 2007, The EMBO journal.
[25] K. Honda,et al. IRFs: master regulators of signalling by Toll-like receptors and cytosolic pattern-recognition receptors , 2006, Nature Reviews Immunology.
[26] Yu Xue,et al. PPSP: prediction of PK-specific phosphorylation site with Bayesian decision theory , 2006, BMC Bioinformatics.
[27] V. Nizet,et al. Innate Immunity Gone Awry: Linking Microbial Infections to Chronic Inflammation and Cancer , 2006, Cell.
[28] F. Liew,et al. Negative regulation of Toll-like receptor-mediated immune responses , 2005, Nature Reviews Immunology.
[29] K. Honda,et al. Spatiotemporal regulation of MyD88–IRF-7 signalling for robust type-I interferon induction , 2005, Nature.
[30] A. Godzik,et al. A Novel PAAD-containing Protein That Modulates NF-κB Induction by Cytokines Tumor Necrosis Factor-α and Interleukin-1β* , 2002, The Journal of Biological Chemistry.
[31] J. Tschopp,et al. The Inflammasomes , 2010, Cell.
[32] T. Maniatis,et al. IKKepsilon and TBK1 are essential components of the IRF3 signaling pathway. , 2003, Nature immunology.
[33] A. Godzik,et al. A novel PAAD-containing protein that modulates NF-kappa B induction by cytokines tumor necrosis factor-alpha and interleukin-1beta. , 2002, The Journal of biological chemistry.